Snakebite & Envenomation MCQ Quiz | Poisonings & Environmental

Quiz Introduction

Welcome to this specialized quiz on Snakebite and Envenomation, designed for MBBS students. This quiz will test your understanding of the critical aspects of snakebite management, from identifying venomous species and understanding venom pathophysiology to applying correct first aid and advanced clinical interventions. Covering neurotoxic, hemotoxic, and myotoxic syndromes, the questions delve into diagnosis, laboratory findings like the 20WBCT, and the proper administration and management of Anti-Snake Venom (ASV), including its potential adverse reactions. This comprehensive assessment will help you solidify your knowledge for both theoretical exams and practical clinical scenarios. After completing the quiz, you can download all questions with their correct answers in a PDF format for future revision.

1. The 20-minute whole blood clotting time (20WBCT) is a crucial bedside test primarily used to detect which type of envenomation?

2. Ptosis, dysphagia, and descending respiratory paralysis are classical signs of envenomation by which family of snakes?

3. Which of the following is the most appropriate first aid measure for a snakebite victim in a field setting?

4. The venom of which of the “Big Four” Indian snakes is notorious for causing Acute Kidney Injury (AKI)?

5. What is the primary mechanism of action of polyvalent anti-snake venom (ASV)?

6. The venom of the Common Krait is predominantly neurotoxic. A key clinical feature distinguishing it from a Cobra bite is:

7. A patient develops urticaria, bronchospasm, and hypotension 20 minutes after starting an ASV infusion. What is the immediate management step?

8. The “syndromic approach” to snakebite management is based on:

9. What is the role of neostigmine and atropine in the management of snakebite envenomation?

10. A patient presents with dark brown, “cola-colored” urine and severe muscle pain after being bitten by a snake. This presentation is highly suggestive of:

11. Compartment syndrome, characterized by severe pain, swelling, and neurological deficits in a limb, is a known complication of envenomation by which type of snake?

12. Which of the following is NOT part of the “Big Four” venomous snakes responsible for most deaths in India?

13. According to National Snakebite Management Protocol, what is the recommended initial dose of polyvalent ASV for an adult with signs of systemic envenomation?

14. Which venom component is primarily responsible for the procoagulant effect seen in viper bites, leading to a consumptive coagulopathy?

15. The Elapidae family of snakes (e.g., Cobras, Kraits) are characterized by which type of fang structure?

16. What is the main reason for avoiding Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for pain management in snakebite victims?

17. A bite from a sea snake (Hydrophiinae) typically results in which dominant clinical syndrome?

18. After administering the initial dose of ASV for a viperine bite, what is the best indicator to decide if a repeat dose is needed?

19. Which snakebite is classically associated with abdominal pain, which can mimic an acute abdomen?

20. The term ‘dry bite’ in the context of snakebites refers to a bite where:

21. Tetanus prophylaxis is recommended for all snakebite victims because:

22. Serum sickness is a delayed hypersensitivity reaction to ASV that typically occurs:

23. In a patient with cobra envenomation, respiratory failure is primarily due to paralysis of the:

24. What is the most reliable feature to distinguish a venomous snake from a non-venomous one in India?

25. A patient with snakebite has a normal 20WBCT, no bleeding manifestations, and no neurological signs. What is the appropriate next step?